Search results
India to manufacture medication for diabetes, obesity under PLI by 2026: Report
Firstpost· 4 days agoIncentives are being planned by India in 2026 to encourage domestic production of GLP-1 medications,...
India plans incentives for diabetes, obesity drug makers in 2026, government official says - ET...
The Economic Times· 4 days agoBengaluru: India is planning to offer incentives to promote local manufacturing of GLP-1 drugs used...
HFT Scan: Ceat and India Cements in focus
CNBC Awaaz· 2 days agoCeat and India Cements closed higher on June 28.
ETHealthworld to host third edition of India Diagnostics Summit - ET HealthWorld
The Economic Times· 5 days agoThe third edition of the India Diagnostics Summit 2024, is poised to be an unparalleled event centred on the theme 'Diagnosing Tomorrow: Advancing Healthcare Through Innovation'. This summit ...
Taking Stock: Record run continues for 2nd day; Nifty Bank around 53,000
CNBC Awaaz· 6 days agoBiggest gainers on the Nifty included Reliance Industries, UltraTech Cement, Bharti Airtel, ICICI...
Defence component supplier TechEra Engineering to raise Rs 35 crore via IPO
CNBC Awaaz· 4 days agoThe price band is estimated to be in the range of Rs 75-80 and the company is looking to list by the second half of July, according to a person familiar with the process.
Taking Stock: Market fails to hold record high; surges 6.5% in June
CNBC Awaaz· 4 days agoFor the week, BSE Sensex and Nifty50 index added 2 percent each, however, for the month of June...